- What We Do
- Get Involved
- Our Impact
- Our Events
- Boston Bakes for Breast Cancer
- Cape & Islands Bakes for Breast Cancer
- Rhode Island Bakes for Breast Cancer
- Cooking Classes
- Bake Sale
- Office Bake Sale
- Event Registration
- Contact Us
Tag Archives: metastatic breast cancer
With a breadth that addresses all types of breast
and gynecologic cancers – from the common to the
obscure, the early-stage to the advanced – the Susan F.
Smith Center for Women’s Cancers at Dana-Farber is
propelling the science and fine-tuning patient care for
women (and in a few cases, men) of all ages.
The center’s research and care expertise is growing
in four major areas where patients find themselves in
particular need of assistance: breast surgery, metastatic
breast cancer, breast cancer in young women, and
recurrent ovarian cancer.
Colleen Sullivan was prepared to follow a typical plan
for her breast cancer: a lumpectomy followed by radia-
tion. When she learned a …
Metastatic breast cancer (MBC), also known as stage IV breast cancer or advanced stage breast cancer, ultimately affects approximately 20-25 percent of all people with breast cancer. There is no cure for MBC, but new developments in treatment and research are helping patients live longer and experience a better quality of life.
“There are women who live with MBC for many years, often five, ten years or more,” says Eric Winer, MD, director of the Breast Oncology Program in the Susan F. Smith Center for Women’s Cancers at Dana-Farber. “Although some women with metastatic breast cancer still face a shorter life …
When people hear the words metastatic breast cancer, A lot of them have no idea what it means. I know we hear a lot of talk about breast cancer in the month of October. Yet very little about male breast cancer or metastatic breast cancer. Metastatic breast cancer means that cancer has traveled outside of the breast area. It usually spreads to the bones, brain, lung or liver. At this point it is considered stage four, with no cure. It is considered a terminal disease at that point. They are trying to make it a chronic disease. This also means …
Will an emerging cancer therapy that links potent drugs to tumor-seekers take the place of standard chemotherapy?
by Elizabeth Dougherty
Eric Winer, MD (left), has been leading clinical trials at DF/BWCC focusing on the antibody-drug conjugate T-DM1.
Sarah Merchant was working as a Web designer in Boston when, at age 28, she was diagnosed with stage 4 metastatic breast cancer. Surgery, radiation, and a series of chemotherapy regimens followed, as did nerve damage, hair loss, and a general decline in her health.
Then Merchant heard about T-DM1, a trial drug promising the effectiveness of chemotherapy without the toxicity. “I wanted to get into that …
I could not use another title. Being a former marathoner, doing Boston like ten times, I can’t help but be touched in so many ways by this bombing. I have a few of my friends still running in this great event and many others watching it.
Luckily none of friends or family got hurt. My thoughts and energy go out to to all who were victims of this event. I will not give these horrible people any of my energy, it reminds us that there are still some bad people in the world. What I would love to focus is …
Male breast cancer…..
Someday it will be a word everyone has heard of and familiar with. However, right now most men have no idea they can get this crazy disease. Approximately 2140 men per year are diagnosed and 440 men die from this disease each year.
Thirty years ago is about the time when women really started talking about breast cancer and raising awareness and of course raising a lot of money since then. As money is constantly raised for breast cancer in the Billions we are still no closer to a cure. I am affiliated with a group called NBCC. This …
Harold J. Burstein, MD, PhD, a Dana-Farber breast cancer specialist, discusses some of the important studies presented at the 2011 CTRC-AACR San Antonio Breast Cancer Symposium.
The five-day meeting includes more than 1,000 scientific presentations, seminars, and posters, with a focus on emerging treatments in hard-to-treat populations, patients with metastatic breast cancer, and breast cancer prevention and risk.
Around 8,000 breast cancer experts from 90 countries are attending the symposium to learn about the latest developments in breast cancer care and research.
View Report from San Antonio Breast Cancer 2011 Symposium You Tube Video with Dr. Harold Burstein
Courtesy of Dana-Farber Cancer Institute
Tags: Breast …